Zobrazeno 1 - 3
of 3
pro vyhledávání: '"MJ Lamas-Diaz"'
Autor:
B Bernardez-Ferran, E Lopez-Montero, MJ Lamas-Diaz, B Sanchez-Iglesias, A Mosquera-Torre, M Touris-Lores
Publikováno v:
Patient safety and risk management.
Background It is believed that allopurinol alters the metabolism of mercaptopurine in favour of 6-thioguanine nucleotide (6TGN), decreasing the production of 6-methyl-mercaptopurine (6MMP). 6TGN is responsible for leukocyte suppression, and 6MMP is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::654efb62dd1a02d741cf6d18cdf20428
https://doi.org/10.1136/ejhpharm-2017-000640.592
https://doi.org/10.1136/ejhpharm-2017-000640.592
Autor:
A Suarez-Rodriguez, R García-Ramos, C Gonzalez-Anleo, J Rojo-Valdes, MJ Lamas-Diaz, P Suarez-Artime, A Hermida-Cao, M Rodriguez-Cobos, A Martos-Rosa, I Zarra-Ferro
Publikováno v:
European Journal of Hospital Pharmacy. 23:A154.2-A154
Background In 2011, pirfenidone was the first drug to be approved for the treatment of idiopathic pulmonary fibrosis (IPF) in Europe after reduced decline in per cent predicted forced vital capacity (FVC) in two phase III trials. Purpose To describe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b9af8a4c3f23adb6e1c487d3822ca63
https://doi.org/10.1136/ejhpharm-2016-000875.348
https://doi.org/10.1136/ejhpharm-2016-000875.348
Autor:
Goyanes A; FabRx Ltd., 3 Romney Road, Ashford, Kent TN24 0RW, UK; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma Group (GI-1645), Universidade de Santiago de Compostela, 15782, Spain. Electronic address: a.goyanes@FabRx.co.uk., Madla CM; UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK., Umerji A; UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK., Duran Piñeiro G; Pharmacy Department, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Travesía Choupana s/n, Santiago de Compostela 15706, Spain., Giraldez Montero JM; Pharmacy Department, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Travesía Choupana s/n, Santiago de Compostela 15706, Spain., Lamas Diaz MJ; Pharmacy Department, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Travesía Choupana s/n, Santiago de Compostela 15706, Spain., Gonzalez Barcia M; Pharmacy Department, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Travesía Choupana s/n, Santiago de Compostela 15706, Spain., Taherali F; UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK., Sánchez-Pintos P; Servicio de Neonatología, Unidad de Diagnóstico y Tratamiento de Enfermedades Metabólicas Congénitas, Hospital Clínico Universitario de Santiago de Compostela, Universidad de Santiago de Compostela, IDIS, CIBERER, MetabERN, Spain., Couce ML; Servicio de Neonatología, Unidad de Diagnóstico y Tratamiento de Enfermedades Metabólicas Congénitas, Hospital Clínico Universitario de Santiago de Compostela, Universidad de Santiago de Compostela, IDIS, CIBERER, MetabERN, Spain., Gaisford S; FabRx Ltd., 3 Romney Road, Ashford, Kent TN24 0RW, UK; UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK., Basit AW; FabRx Ltd., 3 Romney Road, Ashford, Kent TN24 0RW, UK; UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK. Electronic address: a.basit@ucl.ac.uk.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2019 Aug 15; Vol. 567, pp. 118497. Date of Electronic Publication: 2019 Jul 04.